GNRH1 and metastatic malignant neoplasm in the lymph nodes: As for the endocrine therapy, the age of this patient was around 40 years old, and considering the number of axillary lymph node metastases, ovarian suppressive function using luteinizing hormone-releasing hormone (LH-RH) agonist might be suitable for this case.